{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0000353278","name":"NOVO NORDISK A S","summary":"Novo Nordisk A/S is a global healthcare company and world leader in Obesity and Diabetes care. Headquartered in Denmark, it discovers, develops, manufactures, and markets pharmaceutical products including GLP-1 receptor agonists (Ozempic, Wegovy, Saxenda), modern and human insulins, and a Rare disease portfolio covering growth hormone and haemophilia products. It employs over 69,500 people and markets products in approximately 170 countries.","people":[],"products":[{"name":"Ozempic","type":"service","description":"GLP-1 receptor agonist for treatment of type 2 diabetes; leading product by sales."},{"name":"Wegovy","type":"service","description":"Injectable GLP-1 receptor agonist for treatment of obesity; revenue grew 36% to DKK 79 billion."},{"name":"Wegovy Pill","type":"service","description":"Oral formulation of Wegovy for obesity treatment; launched in first quarter of 2026."},{"name":"Saxenda","type":"service","description":"Injectable GLP-1 receptor agonist marketed for the treatment of obesity."},{"name":"Modern and human insulins","type":"service","description":"Insulin products for the treatment of diabetes."},{"name":"Growth hormone products","type":"service","description":"Rare disease portfolio product for growth hormone deficiency treatment."},{"name":"Haemophilia products","type":"service","description":"Rare disease portfolio products for treatment of haemophilia."},{"name":"Efruxifermin (EFX)","type":"service","description":"Akero Therapeutics lead candidate in Phase 3 for metabolic dysfunction-associated steatohepatitis (MASH)."}],"partnerships":[],"affiliations":[],"origin":{"leaf":"6d7efc3d7cc93f1be399e0ab36219b8b12659e3bdfb15ffe1b9646b8520f44a6","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"33cfdbdcc6c537c4e19a695dadfd45fd406025d18f960d360890f7732abaebf8","parent":"59ed99c026a7af159d9c8ce4193d002f7e08a8209477f06d9886cb1da68afbc4","source":"0000353278-26-000012","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}